Real-world outcomes of advanced NSCLC patients with common and uncommon/complex EGFR mutation profiles Published September 2019 Citation Riely, GJ, Lovly, CM, Messina, CGM, Bienert, S, Alexander, K, Pao, W, Magee, K, Baxi, SS, Doebele, RC. . World Conference on Lung Cancer. . Authors:Riely, GJ, Lovly, CM, Messina, CGM, Bienert, S, Alexander, K, Pao, W, Magee, K, Baxi, SS, Doebele, RC Sources:World Conference on Lung Cancer Share Posted inPublicationsUnmet need More publicationsASCO Annual MeetingMay 2026From plenary to practice: A large language model (LLM)-based thematic analysis of landmark clinical trial discussions and factors influencing their real-world adoptionCohen AB, Williams T, Aggarwal C, et al.Publication summaryPublicationsMachine learningArtificial intelligenceASCO Annual MeetingMay 2026Comparison of real-world overall survival between atezolizumab- and durvalumab-containing first- line induction and maintenance regimens in extensive-stage small cell lung cancerGanti AK, Snider J, Yan J, et al.Publication summaryPublicationsComparative effectivenessSmall cell lung cancerASCO Annual MeetingMay 2026Drivers of organotropism and patterns of metastatic progression in metastatic non-small cell lung cancerPublication summaryPublicationsNon-small cell lung cancer